Welcome to our dedicated page for Nano-X Imaging news (Ticker: NNOX), a resource for investors and traders seeking the latest updates and insights on Nano-X Imaging stock.
NANO-X IMAGING LTD reports news on an integrated medical imaging and healthcare services platform built around Nanox.ARC multisource digital tomosynthesis systems, AI and software solutions, cloud-based workflow tools, remote radiology access, health information technology and a marketplace model. Company updates commonly cover U.S. commercialization, distribution agreements, clinical collaborations and regulatory clearances tied to Nanox.ARC and related imaging capabilities.
Recurring financial and operating news also includes results from teleradiology services, imaging products and services, AI and software activity, and the completed addition of Nanox Health IT. The company frames its commercial activity around broader access to 3D imaging and preventive-care workflows across clinical settings.
Nanox Imaging Ltd (NASDAQ: NNOX) is set to showcase its advanced medical imaging technology, including the Nanox.SOURCE and Nanox.ARC systems, at the RSNA 2020 event from November 29 to December 5 in Chicago. The demonstration, led by CEO Ran Poliakine, will feature live imaging sessions and discussions about clinical applications, aiming to enhance global access to preventive healthcare through affordable imaging solutions. With two-thirds of the world lacking medical imaging access, Nanox's initiative aims to address this gap and promote early detection.
NANO-X IMAGING LTD (NASDAQ: NNOX) appointed Gilad Yron as Chief Business Officer to enhance its MSaaS agreements and refine commercial strategy. His role aims to oversee customer-facing activities and lead the deployment of over 5,100 Nanox.ARC systems, pending regulatory approvals. Ran Poliakine, Chairman and CEO, emphasized the importance of a world-class team to drive success and democratize medical imaging. Yron's prior experience includes leadership roles at Kornit Digital and Stratasys Ltd, indicating a strong focus on innovation in technology.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced that its CEO, Ran Poliakine, will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit from September 21-23, 2020. The presentation is scheduled for September 22, 2020, at 9:10 am ET. The event will be webcast live, with access available through both a dedicated link and the company's website. Nanox focuses on developing a cost-effective digital X-ray source for real-world medical applications aimed at improving early detection services.
NANO-X IMAGING LTD (NASDAQ: NNOX) responded to unusual trading activities attributed to a Citron Research report dated September 15, 2020. The Company refutes the report's allegations, labeling them as baseless and misleading. Nanox is investigating the claims and promises to provide further clarity as necessary. Founded by Ran Poliakine, Nanox is focused on developing a cost-effective digital X-ray source aimed at improving medical imaging accessibility.
NANO-X IMAGING LTD (NASDAQ: NNOX) announced participation in two investor conferences. The first event is the Jefferies Asia Forum on September 16, 2020, at 4:00 PM HK time, followed by the Cantor Virtual Global Healthcare Conference on September 15, 2020, at 9:20 AM EDT. Audio for both events will be available via webcast on the company's website, with archives accessible for 90 days. Founded by Ran Poliakine, Nanox develops innovative digital X-ray technology aimed at reducing medical imaging costs and improving accessible healthcare.